Farmaceutica Remedia Posts RON 763M Revenues, RON 8.7M Net Profit in 2025
Source: ZF English Farmaceutica Remedia, a leading player on the drug wholesale market, posted RON763.2 million operating income in 2025, up 2% from 2024, while
Source: ZF English Farmaceutica Remedia, a leading player on the drug wholesale market, posted RON763.2 million operating income in 2025, up 2% from 2024, while
REMEDIA got a perfect score for the fifth year in a row in the VEKTOR assessment done by ARIR – the Romanian Investor Relations Association.
Farmaceutica REMEDIA received the Diploma of Excellence at the Regional Gala “Romania is YOU” – South-West Edition! At the event held on Wednesday, November 12,
REMEDIA reaffirms its commitment to promoting excellence and local sporting values by supporting the National Individual Women’s Artistic Gymnastics Championship, organized by the Romanian Gymnastics
Farmaceutica REMEDIA participated in the annual meeting of international partners organized by BD Rowa, held in Rome, an event dedicated to the exchange of experience,
Farmaceutica Remedia was present today at the Forum by ARIR through our ESG officer, Cora Țăruș. An event with substance, organized in the distinctive ARIR
Read the full interview & report here.
For the fourth year in a row, Farmaceutica REMEDIA has achieved the top 10 in the VEKTOR by ARIR ranking for 2024. This acknowledgment reflects
The 19th edition of the “Retezat International Contemporary Art Symposium” took place from the beginning of July 2024 and ended with a vernissage of the
REMEDIA, in the Top 10 of the largest companies in the distribution of medicines, according to the Business Yearbook of Romania 2024 – The biggest